Analgesic tolerance and cross-tolerance to the cannabinoid receptors ligands hemopressin, VD-hemopressin(α) and WIN55,212-2 at the supraspinal level in mice-Reference-Cited by-同舟云学术

Analgesic tolerance and cross-tolerance to the cannabinoid receptors ligands hemopressin, VD-hemopressin(α) and WIN55,212-2 at the supraspinal level in mice

Published:2014-08 Issue: Volume:578 Page:187-191
ISSN:0304-3940
Container-title:Neuroscience Letters
language:en
Short-container-title:Neuroscience Letters

Author:

Pan Jia-Xin,Wang Zi-Long,Li Ning,Han Zheng-Lan,Li Xu-Hui,Tang Hong-Hai,Wang Pei,Zheng Ting,Fang Quan,Wang Rui

Publisher

Elsevier BV

Subject

General Neuroscience

Reference21 articles.

1. Hemopressin is an inverse agonist of CB1 cannabinoid receptors;Heimann;Proc. Natl. Acad. Sci. U S A,2007

2. Novel endogenous peptide agonists of cannabinoid receptors;Gomes;FASEB J.,2009

3. The peptide hemopressin acts through CB1 cannabinoid receptors to reduce food intake in rats and mice;Dodd;J. Neurosci.,2010

4. Novel natural peptide substrates for endopeptidase 24.15, neurolysin, and angiotensin-converting enzyme;Rioli;J. Biol. Chem.,2003

5. Antinociceptive action of hemopressin in experimental hyperalgesia;Dale;Peptides,2005

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MP-13, a novel chimeric peptide of morphiceptin and pepcan-9, produces potent antinociception with limited side effects;Neuropeptides;2024-10

2. The electrophysiological and behavioral evaluation of the peptide hemopressin and cannabinoid CB1 receptor agonist and antagonist in pentylenetetrazol model of epilepsy in rats;Pflügers Archiv - European Journal of Physiology;2023-04-27

3. Microglial Cannabinoid CB2 Receptors in Pain Modulation;International Journal of Molecular Sciences;2023-01-25

4. Characterization of pepcan-23 as pro-peptide of RVD-hemopressin (pepcan-12) and stability of hemopressins in mice;Advances in Biological Regulation;2021-05

5. Hemopressin as a breakthrough for the cannabinoid field;Neuropharmacology;2021-02